1. Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins 
E.J. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis 
Clinical Microbiology and Infection 
Volume 22, Issue 6, Pages (June 2016)
DOI: /j.cmi
Copyright © 2016 The Authors Terms and Conditions

2. Fig. 1
Case–control matching process. Abbreviations: CCI, Charlson's Co-morbidity Index; IgGAM, IgM-enriched polyclonal immunoglobulin preparation; MDR, multidrug-resistant.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2016 The Authors Terms and Conditions

3. Fig. 2
Survival plots for the patients treated with an IgM-enriched polyclonal immunoglobulin preparation (IgGAM) and the comparator group until day 28; statistical comparison between the two groups is shown.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2016 The Authors Terms and Conditions

4. Fig. 3
Time to breakthrough bacteraemia for cases treated with an IgM-enriched polyclonal immunoglobulin preparation (IgGAM) and matched comparators; statistical comparison between the two groups is shown.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2016 The Authors Terms and Conditions